Publications by authors named "Lila Yang"

Claim this Profile
S
Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design.
Haiying Qin, Lila Yang, John A Chukinas, Nirali Shah, Samiksha Tarun

J Immunother Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of leukemic burden via bone-targeted nanoparticle delivery of an inhibitor of C-chemokine (C-C motif) ligand 3 (CCL3) signaling.
Marian A Ackun-Farmmer, Celia A Soto, Maggie L Lesch, Daniel Byun, Lila Yang

FASEB J· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression, refolding and spectroscopic characterization of fibronectin type III (FnIII)-homology domains derived from human fibronectin leucine rich transmembrane protein (FLRT)-1, -2, and -3.
Lila Yang, Maria Hansen Falkesgaard, Peter Waaben Thulstrup, Peter Schledermann Walmod, Leila Lo Leggio

PeerJ· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis